| Financial Year |
March 31 2023 |
| Monetary Funds |
1,022,965,970.70 |
| Held-for-trading Financial Assets |
15,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
454,387,058.21 |
| Advances to Suppliers |
25,484,326.14 |
| Other Receivables |
20,213,204.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
370,920,557.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,066,864.99 |
| Total Current Assets |
1,967,673,150.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,688,827.87 |
| Investment Properties |
-- |
| Fixed Assetes |
861,745,991.86 |
| Under-construction Projects |
103,205,617.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
69,359,878.39 |
| R&D expenses |
1,789,931.38 |
| Goodwill |
130,318,682.15 |
| Long-Term Deferred and Prepaid Expenses |
23,643,604.04 |
| Deferred Income Tax Assets |
21,709,665.93 |
| Other Non-Current Assets |
70,992,652.11 |
| Sub-Total of Non-Current Assets |
1,629,147,866.12 |
| Total Assets |
3,596,821,017.08 |
| Short-Term Loans |
138,144,166.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
13,200,000.00 |
| Accounts Payable |
434,748,403.56 |
| Accounts Received In Advance |
676,698.29 |
| Employee Compensation Payable |
18,226,667.80 |
| Taxes Payable |
47,024,982.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
27,254,439.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,752,644.50 |
| Other Current Liabilities |
336,547.01 |
| Sub-Total of Current Liabilities |
683,964,211.03 |
| Long-term Loans |
10,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
56,297,917.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
101,677,140.43 |
| Total Liabilities |
785,641,351.46 |
| Paid-In Capital(Or Share Stock) |
701,387,335.00 |
| Capital Surplus |
1,135,368,907.84 |
| Surplus Reserve |
84,291,784.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
689,964,888.42 |
| Minority Stockholder's Interest |
54,561,308.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,756,618,357.18 |
| Owner's Equity（Stockholder's Equity） |
2,811,179,665.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,596,821,017.08 |
